Replies to post #2280 on Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

I see it differently. Even if the #s don't match the preliminary results we saw last Oct, the #s are still out of the park if they remain where they are at. Think of it this way, pozi will become the standard of care for the 20,000 patients w EGFR/HER2 ex20ins in NSCLC in a relapsed setting. Can't wait to see what it does in a 1st line setting.